GlassScriptPhysician profile
Thomas Alan Vogel
NPI 1265490015
$1,263.12
in general payments reported to CMS, 2019-2025
22 companies · $306 in 2025
The $306 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $174 · 2020: $183 · 2021: $125 · 2022: $150 · 2023: $218 · 2024: $107 · 2025: $306.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $162.40 | 2022-2025 | Nuzyra |
| Tactile Systems Technology INC | $144.62 | 2019-2025 | Nimbl, Flexitouch Plus |
| Ani Pharmaceuticals, INC. | $134.14 | 2022-2025 | Purified Cortrophin Gel |
| Treace Medical Concepts, INC. | $99.84 | 2022-2025 | |
| Horizon Therapeutics Plc | $95.53 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $87.78 | 2020-2021 | |
| Medtronic, INC. | $68.90 | 2022-2023 | Intellis Adaptivestim |
| Zyla Life Sciences, INC. | $68.57 | 2020 | |
| Stryker Corporation | $68.18 | 2019-2025 | Easyfuse, Ortholoc 3di |
| Smith+Nephew, INC. | $47.94 | 2021-2025 | Taylor Spatial Frame |
| Kerecis Limited | $39.82 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Djo, LLC | $34.38 | 2019-2023 | Donjoy |
| Boston Scientific Corporation | $33.74 | 2024-2025 | Wavewriter Alpha Prime 16 |
| Globus Medical, INC. | $27.85 | 2025 | Senza |
| Depuy Synthes Sales INC. | $26.38 | 2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grt US Holding, INC. | $24.30 | 2022 | |
| Arthrosurface Incorporated | $18.83 | 2019 | |
| Averitas Pharma INC. | $17.90 | 2023 | Qutenza |
| Orthofix Medical, INC. | $17.57 | 2023 | Physio-Stim |
| Paragon 28, INC. | $16.20 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.25 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $14.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Vogel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.